Duquesne
Computational Modeling of the Binding of Amyloid-Beta to Neprilysin for Facilitating the Development of a Potential Alzheimer's Disease Therapy
Abstract
dc:description.abstractThe zinc metalloprotease neprilysin (NEP) has been shown to degrade small bioactive peptides. Crystal structures of seven NEP-inhibitor complexes and biochemical characterization of NEP activity have highlighted amino acid interactions that are crucial to ligand binding. Studies also indicate that NEP is one of a select group of metalloenzymes that degrade the amyloid-beta peptide (Aß) in vivo and in situ. Accumulation of neurotoxic Aß aggregates in the brain appears to be a causative agent in the pathophysiology of Alzheimer's Disease (AD). For this reason the enzymatic degradation of Aß has been studied extensively, but little is known about specific binding interactions underlying NEP degradation of Aß. Using known crystal structures of NEP, we have conducted comparative computational studies of ligand binding that predict NEP residues Arg 102 and 110 form binding interactions specific to Aß. These interactions may provide insight for using NEP degradation of Aß in AD therapy.
Degree
thesis:*- Name thesis:degree_name
- MS
- Level thesis:degree_level
- Immediate Access
- Discipline thesis:degree_discipline
- Chemistry and Biochemistry
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Pope, Darrick E.
- Contributors dc:contributor
-
- Michael Cascio
- Jeffry Madura
- Rita Mihailescu
Subjects
dc:subject × 6Rights
- Language dc:language
- English
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://dsc.duq.edu/etd/1507